Sinopharm Group Co. Ltd. (HKG: 1099)
Hong Kong
· Delayed Price · Currency is HKD 21.45
-0.05 (-0.23%)
Dec 20, 2024, 4:08 PM HKT
Sinopharm Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 590,346 | 596,570 | 552,148 | 521,051 | 456,415 | 425,273 | Upgrade
|
| Revenue Growth (YoY) | -0.22% | 8.05% | 5.97% | 14.16% | 7.32% | 23.44% | Upgrade
|
| Cost of Revenue | 543,162 | 548,058 | 504,713 | 477,001 | 416,091 | 387,741 | Upgrade
|
| Gross Profit | 47,184 | 48,512 | 47,434 | 44,051 | 40,323 | 37,531 | Upgrade
|
| Selling, General & Admin | 26,153 | 26,161 | 24,914 | 23,210 | 21,203 | 19,482 | Upgrade
|
| Other Operating Expenses | -480.4 | -582.01 | -676.16 | -589.19 | -652 | -441.16 | Upgrade
|
| Operating Expenses | 26,321 | 26,193 | 24,670 | 23,067 | 21,221 | 19,356 | Upgrade
|
| Operating Income | 20,863 | 22,318 | 22,764 | 20,984 | 19,102 | 18,176 | Upgrade
|
| Interest Expense | -2,646 | -2,946 | -3,509 | -3,745 | -3,413 | -3,429 | Upgrade
|
| Interest & Investment Income | 822.51 | 783.41 | 555.82 | 590.55 | 708.77 | 521.76 | Upgrade
|
| Earnings From Equity Investments | 1,158 | 1,107 | 1,067 | 1,070 | 987.46 | 887.07 | Upgrade
|
| Currency Exchange Gain (Loss) | -18.52 | -9.98 | -2.39 | -10.51 | 11.81 | -12.81 | Upgrade
|
| Other Non Operating Income (Expenses) | -443.31 | -291.8 | -464.32 | -339.47 | -436.02 | -380.34 | Upgrade
|
| EBT Excluding Unusual Items | 19,736 | 20,962 | 20,411 | 18,549 | 16,961 | 15,762 | Upgrade
|
| Impairment of Goodwill | -27.02 | -27.02 | -38.98 | -396.06 | -156.29 | -140.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,891 | -1,986 | -1,892 | -1,094 | -1,320 | -1,896 | Upgrade
|
| Gain (Loss) on Sale of Assets | 357.62 | 492.31 | 3.11 | 65.87 | 152.96 | 34.6 | Upgrade
|
| Asset Writedown | -27.88 | -27.88 | -16.81 | -210.8 | -108.81 | -41.16 | Upgrade
|
| Other Unusual Items | 95.12 | 98.92 | 97.81 | 88.71 | 68.74 | 40.82 | Upgrade
|
| Pretax Income | 18,243 | 19,512 | 18,564 | 17,003 | 15,598 | 13,760 | Upgrade
|
| Income Tax Expense | 4,227 | 4,502 | 4,218 | 3,938 | 3,501 | 3,140 | Upgrade
|
| Earnings From Continuing Operations | 14,016 | 15,010 | 14,345 | 13,065 | 12,097 | 10,620 | Upgrade
|
| Minority Interest in Earnings | -5,363 | -5,956 | -5,820 | -5,306 | -4,910 | -4,368 | Upgrade
|
| Net Income | 8,653 | 9,054 | 8,526 | 7,759 | 7,187 | 6,253 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.07 | 1.18 | Upgrade
|
| Net Income to Common | 8,653 | 9,054 | 8,526 | 7,759 | 7,187 | 6,251 | Upgrade
|
| Net Income Growth | -3.17% | 6.19% | 9.89% | 7.95% | 14.95% | 7.14% | Upgrade
|
| Shares Outstanding (Basic) | 3,117 | 3,117 | 3,117 | 3,121 | 3,111 | 2,970 | Upgrade
|
| Shares Outstanding (Diluted) | 3,117 | 3,117 | 3,117 | 3,121 | 3,111 | 2,972 | Upgrade
|
| Shares Change (YoY) | -0.06% | - | -0.12% | 0.30% | 4.70% | - | Upgrade
|
| EPS (Basic) | 2.78 | 2.90 | 2.74 | 2.49 | 2.31 | 2.11 | Upgrade
|
| EPS (Diluted) | 2.78 | 2.90 | 2.74 | 2.49 | 2.31 | 2.10 | Upgrade
|
| EPS Growth | -3.11% | 6.19% | 10.02% | 7.63% | 10.00% | 7.14% | Upgrade
|
| Free Cash Flow | 17,242 | 15,213 | 18,837 | 7,234 | 9,257 | 16,571 | Upgrade
|
| Free Cash Flow Per Share | 5.53 | 4.88 | 6.04 | 2.32 | 2.98 | 5.58 | Upgrade
|
| Dividend Per Share | 0.870 | 0.870 | 0.820 | 0.750 | 0.690 | 0.600 | Upgrade
|
| Dividend Growth | 6.10% | 6.10% | 9.33% | 8.70% | 15.00% | 1.69% | Upgrade
|
| Gross Margin | 7.99% | 8.13% | 8.59% | 8.45% | 8.83% | 8.83% | Upgrade
|
| Operating Margin | 3.53% | 3.74% | 4.12% | 4.03% | 4.19% | 4.27% | Upgrade
|
| Profit Margin | 1.47% | 1.52% | 1.54% | 1.49% | 1.57% | 1.47% | Upgrade
|
| Free Cash Flow Margin | 2.92% | 2.55% | 3.41% | 1.39% | 2.03% | 3.90% | Upgrade
|
| EBITDA | 23,023 | 24,404 | 24,777 | 22,896 | 20,882 | 19,892 | Upgrade
|
| EBITDA Margin | 3.90% | 4.09% | 4.49% | 4.39% | 4.58% | 4.68% | Upgrade
|
| D&A For EBITDA | 2,160 | 2,085 | 2,012 | 1,912 | 1,780 | 1,716 | Upgrade
|
| EBIT | 20,863 | 22,318 | 22,764 | 20,984 | 19,102 | 18,176 | Upgrade
|
| EBIT Margin | 3.53% | 3.74% | 4.12% | 4.03% | 4.19% | 4.27% | Upgrade
|
| Effective Tax Rate | 23.17% | 23.07% | 22.72% | 23.16% | 22.44% | 22.82% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.